When and how often to screen for cervical cancer in three low- and middle-income countries: A cost-effectiveness analysis Fulltext Access 21 Pages 2015
Effectiveness of less than three doses of quadrivalent human papillomavirus vaccine against cervical intraepithelial neoplasia when administered using a standard dose spacing schedule: Observational cohort of young women in Australia Fulltext Access 15 Pages 2015
Deep sequencing of HPV16 genomes: A new high-throughput tool for exploring the carcinogenicity and natural history of HPV16 infection Fulltext Access 9 Pages 2015
Human papillomavirus-exposed Langerhans cells are activated by stabilized Poly-I:C Fulltext Access 10 Pages 2015
European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination Fulltext Access 10 Pages 2015
Performance of the Xpert HPV assay in women attending for cervical screening Fulltext Access 6 Pages 2015
Involvement of nucleophosmin (NPM1/B23) in assembly of infectious HPV16 capsids Fulltext Access 16 Pages 2015
Estimation of the epidemiological burden of HPV-related anogenital cancers, precancerous lesions, and genital warts in women and men in Europe: Potential additional benefit of a nine-valent second generation HPV vaccine compared to first generation HPV va Fulltext Access 11 Pages 2015
Colposcopic characteristics and Lugol׳s staining differentiate anal high-grade and low-grade squamous intraepithelial lesions during high resolution anoscopy Fulltext Access 8 Pages 2015
Seroconversion following anal and genital HPV infection in men: The HIM study Fulltext Access 7 Pages 2015
Human papillomavirus 16 (HPV16) enhances tumor growth and cancer stemness of HPV-negative oral/oropharyngeal squamous cell carcinoma cells via miR-181 regulation Fulltext Access 10 Pages 2015
An analysis of HPV infection incidence and clearance by genotype and age in men: The HPV Infection in Men (HIM) Study Fulltext Access 10 Pages 2015